We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+11.08%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$436B
AUM Growth
+$36.1B
Cap. Flow
-$3.58B
Cap. Flow %
-0.82%
Top 10 Hldgs %
13.21%
Holding
2,591
New
137
Increased
834
Reduced
1,023
Closed
112

Sector Composition

Rank Sector Weight
1 Healthcare 15.23%
2 Consumer Discretionary 13.68%
3 Financials 13.65%
4 Industrials 11.98%
5 Technology 10.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSMX
1126
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
$17.7M ﹤0.01%
1,295,780
+1,370
+0.1% +$18.9K
BID
1127
DELISTED
Sotheby's
BID
$17.6M ﹤0.01%
331,436
+51,300
+18% +$2.64M
EDE
1128
DELISTED
Empire District Electric
EDE
$17.5M ﹤0.01%
773,015
-240,865
-24% -$5.41M
STWD icon
1129
Starwood Property Trust
STWD
$6.05B
$17.5M ﹤0.01%
783,633
+32,692
+4% +$692K
AUY
1130
DELISTED
Yamana Gold, Inc.
AUY
$17.4M ﹤0.01%
2,022,800
+542,700
+37% +$5.01M
TEX icon
1131
Terex
TEX
$7.76B
$17.4M ﹤0.01%
413,440
-16,520
-4% -$599K
VIRX
1132
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$17.3M ﹤0.01%
17,387
+4
+0% +$4.14K
SPN
1133
DELISTED
Superior Energy Services, Inc.
SPN
$17.3M ﹤0.01%
64,990
-2,432
-4% -$636K
LECO icon
1134
Lincoln Electric
LECO
$15.3B
$17.3M ﹤0.01%
242,180
-2,600
-1% -$183K
RSG icon
1135
Republic Services
RSG
$66B
$17.3M ﹤0.01%
519,875
-497,050
-49% -$16.8M
ARTC
1136
DELISTED
ARTHROCARE CORP
ARTC
$17.2M ﹤0.01%
428,056
-318,931
-43% -$11.8M
STML
1137
DELISTED
Stemline Therapeutics, Inc.
STML
$17.2M ﹤0.01%
876,666
-47,500
-5% -$1.27M
CSWC icon
1138
Capital Southwest
CSWC
$1.61B
$17.1M ﹤0.01%
1,335,414
+31,926
+2% +$392K
AA icon
1139
Alcoa
AA
$13.3B
$17M ﹤0.01%
667,340
+5,826
+0.9% +$129K
WAT icon
1140
Waters Corp
WAT
$40.9B
$17M ﹤0.01%
169,866
-3,000
-2% -$302K
ALGN icon
1141
Align Technology
ALGN
$12.3B
$16.9M ﹤0.01%
295,370
+100,140
+51% +$5.39M
MXL icon
1142
MaxLinear
MXL
$7.06B
$16.6M ﹤0.01%
1,590,631
+89,350
+6% +$769K
OXFD
1143
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$16.5M ﹤0.01%
+853,900
New +$15.1M
BBY icon
1144
Best Buy
BBY
$18B
$16.3M ﹤0.01%
409,374
+4,100
+1% +$168K
NKTR icon
1145
Nektar Therapeutics
NKTR
$2.59B
$16.3M ﹤0.01%
95,800
+733
+0.8% +$118K
PTLA
1146
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$16.3M ﹤0.01%
633,379
-112,400
-15% -$2.73M
FBIN icon
1147
Fortune Brands Innovations
FBIN
$5.8B
$16.3M ﹤0.01%
417,000
+40,599
+11% +$1.46M
DDC
1148
DELISTED
Dominion Diamond Corporation
DDC
$16.3M ﹤0.01%
1,137,019
-9,900
-0.9% -$133K
AOI
1149
DELISTED
Alliance One International
AOI
$16.2M ﹤0.01%
531,569
-20,940
-4% -$627K
ACCL
1150
DELISTED
Accelrys Inc
ACCL
$16.2M ﹤0.01%
1,699,289
+5,570
+0.3% +$52.3K

Similar funds

T. Rowe Price Associates's Q4 2013 Portfolio in Review

As of Q4 2013, T. Rowe Price Associates held 2,591 positions worth $436B, up 9% from $400B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

T. Rowe Price Associates's Q4 2013 filing shows 137 new, 834 increased, 1,023 reduced and 112 closed positions. Its largest new stake was Twitter, Inc.: 18,211,564 shares worth $1.12B. The largest sale was DELL INC, an estimated $756M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q4 2013 buy was Twitter, Inc.: 18,211,564 shares worth $1.12B.
  • T. Rowe Price Associates added most to DigitalGlobe Inc. in Q4 2013, an estimated $449M increase.
  • T. Rowe Price Associates's biggest Q4 2013 reduction was eBay, cutting an estimated $722M.
  • T. Rowe Price Associates fully exited DELL INC in Q4 2013, selling an estimated $756M.
  • T. Rowe Price Associates's ten largest holdings make up 13% of its $436B portfolio in Q4 2013.
  • T. Rowe Price Associates opened 137 new positions and closed 112 in Q4 2013.
  • T. Rowe Price Associates's portfolio value rose 9% quarter-over-quarter to $436B.

Based on T. Rowe Price Associates's 13F filing for Q4 2013, filed 14 Feb 2014.